Yes. In a clinical trial that directly compared the two lasers, the average repigmentation rate after 12 weeks was 58.2% for PALLAS and 55.4% for the excimer laser — similar effectiveness.
Our research team selected 74 pairs of symmetrical lesions from 21 patients with stable vitiligo. One side was treated with a 308 nm excimer laser and the other with a 311 nm PALLAS laser, twice a week for 12 weeks. Which side received which laser was randomly assigned, and both sides were also treated with Protopic ointment.
After 12 weeks, the average repigmentation rate and the proportion of facial lesions that achieved 75% or more repigmentation were as follows.
| Category | Excimer laser | PALLAS laser |
|---|---|---|
| Overall repigmentation rate | 55.4% | 58.2% |
| Patients who completed treatment | 64.7% | 66.9% |
| 75% or more repigmentation on the face | 60% | 65% |
By body site, both lasers produced good results on the face, but neither showed significant repigmentation on the hands. This is likely because the hands are an area that typically does not respond well to ultraviolet therapy, rather than a difference between the devices.
There was also no significant difference in safety. Some patients experienced erythema lasting more than 48 hours or blisters, but the frequency was similar in both groups, and there were no adverse reactions severe enough to require discontinuation of treatment.
